Market Tracker

04/28 4:45pm ET

Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

2.97
Delayed Data
As of Apr 28
 +0.02 / +0.68%
Today’s Change
2.91
Today|||52-Week Range
25.06
-70.59%
Year-to-Date

Today’s Trading

Previous close2.95
Today’s open2.93
Day’s range2.93 - 3.27
Volume1,273,912
Average volume (3 months)701,331
Market cap$86.9M
Dividend yield--
Data as of 4:00pm ET, 04/28/2016

Growth & Valuation

Earnings growth (last year)-88.89%
Earnings growth (this year)+19.92%
Earnings growth (next 5 years)+23.09%
Revenue growth (last year)+51.47%
P/E ratioNM
Price/Sales1.21
Price/Book0.75

Competitors

 Today’s
change
Today’s
% change
PLXProtalix Biotherapeu...+0.01+0.96%
ADMAADMA Biologics Inc-0.66-8.65%
PIRSPieris Pharmaceutica...0.000.00%
AUPHAurinia Pharmaceutic...+0.03+1.03%
Data as of 4:00pm ET, 04/28/2016

Financials

Last reporting dateApril 29, 2016
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$239.9M
Annual profit (last year)-$73.3M
Net profit margin-30.57%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mary J. Szela
Chief Financial &
Administrative Officer
Gregory D. Perry
Corporate headquarters
Cambridge, Massachusetts

Forecasts